Back

Tissue-resident skeletal muscle macrophages promote recovery from viral pneumonia-induced sarcopenia in normal aging.

Runyan, C. E.; Luo, L.; Welch, L. C.; Lu, Z.; Chen, F.; Schleck, M. J.; Nafikova, R. A.; Grant, R. A.; Piseaux Aillon, R.; Senkow, K. J.; Bunyan, E. G.; Plodzeen, W. T.; Weiss, C.; Dada, L. E.; Thorp, E. B.; Sznajder, J. I.; Chandel, N. S.; Misharin, A. V.; Budinger, G. S.

2025-01-14 immunology
10.1101/2025.01.09.631996 bioRxiv
Show abstract

Sarcopenia, which diminishes lifespan and healthspan in the elderly, is commonly exacerbated by viral pneumonia, including influenza and COVID-19. In a study of influenza A pneumonia in mice, young mice fully recovered from sarcopenia, while older mice did not. We identified a population of tissue-resident skeletal muscle macrophages that form a spatial niche with satellite cells and myofibers in young mice but are lost with age. Mice with a gain-of-function mutation in the Mertk receptor maintained this macrophage-myofiber interaction during aging and fully recovered from influenza-induced sarcopenia. In contrast, deletion of Mertk in macrophages or loss of Cx3cr1 disrupted this niche, preventing muscle regeneration. Heterochronic parabiosis did not restore the niche in old mice. These findings suggest that age-related loss of Mertk in muscle tissue-resident macrophages disrupts the cellular signaling necessary for muscle regeneration after viral pneumonia, offering a potential target to mitigate sarcopenia in aging.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.